Analysts' Top Healthcare Picks: Biofrontera (BFRI), Alpine Immune Sciences (ALPN)
TipRanksMar 19 06:50 ET
Benchmark Reiterates Buy on Biofrontera, Maintains $18 Price Target
BenzingaAug 31, 2023 08:42 ET
Biofrontera Analyst Ratings
BenzingaAug 31, 2023 08:42 ET
Benchmark Adjusts Biofrontera's Price Target to $18 From $140, Keeps Buy Rating
MT NewswiresJul 5, 2023 08:00 ET
Benchmark Maintains Buy on Biofrontera, Lowers Price Target to $18
BenzingaJul 5, 2023 07:50 ET
Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Biofrontera (BFRI) and 2seventy Bio (TSVT)
TipRanksMay 15, 2023 16:31 ET
Benchmark Reiterates Buy on Biofrontera, Maintains $7 Price Target
BenzingaMay 15, 2023 09:29 ET
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Jasper Therapeutics (JSPR) and Biofrontera (BFRI)
TipRanksMar 9, 2023 11:36 ET
Benchmark Adjusts Price Target on Biofrontera to $7 From $11, Reiterates Buy Rating
MT NewswiresJan 31, 2023 10:22 ET
Benchmark Reiterates Buy on Biofrontera, Lowers Price Target to $7
Benzinga Real-time NewsJan 31, 2023 09:43 ET
Biofrontera Analyst Ratings
Benzinga Analyst RatingsJan 31, 2023 09:42 ET
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Biofrontera (BFRI)
TipRanksJul 10, 2022 05:30 ET
No Data
No Data